Harald Lahner

发表

Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT.

O. Pettersson, K. Herrmann, W. Fendler, 2023, European Journal of Nuclear Medicine and Molecular Imaging.